Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKimberly Enterprises Regulatory News (KBE)

  • There is currently no data for KBE

Share purchase by controlling shareholder

8 Jan 2010 10:17

RNS Number : 2481F
Engel East Europe N.V.
08 January 2010
 



FOR IMMEDIATE RELEASE

   8 January 2010

Engel East Europe N.V. 

Share purchase by controlling shareholder

Engel East Europe N.V. ('Engel' or 'the Company'), the AIM-listed Central and Eastern European high-end property developer (EEE: LN), has been notified by Azorim Investment Development & Construction Co. Ltd ('Azorim') that, on 27 October 2008 it acquired 1,625,732 Engel shares at 2.26p per shareand on 2 November 2008 it acquired a further 2,800,000 shares at 2.35p per sharerepresenting in aggregate 5.0 per cent of the total issued share capital of the Company. These shares are held indirectly.

Azorim also holds directly 1,230,000 Engel shares, representing 1.4 per cent of the total issued share capital of the Company.

In addition, Azorim has a controlling interest in Engel General Developers Ltd, which holds 59,996,111 Engel shares representing 68.4 per cent of the issued share capital of Engel. Azorim therefore controls 74.8 per cent of the issued share capital of the Company. Azorim's equitable interest in Engel through its direct holdings and through its interest in Engel General Developers Ltd equates to approximately 52.9 per cent of the issued share capital of Engel.

Mr. Shaya Boymelgreen is a director of Engel and a director of Azorim.

ENDS

Enquiries:

Engel East Europe N.V.

Samuel Hibel

Tel: +972 (9) 970 7004

Libertas Capital Corporate Finance Limited

Tel: +44 (0) 20 7569 9650

Sandy Jamieson

Bankside Consultants

Tel: +44 (0) 20 7367 8888

Simon Bloomfield or Andy Harris

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUWARRRNAARAR
Date   Source Headline
24th Feb 201511:28 amRNSDisposal
19th Jan 20159:19 amRNSDisposal
27th Nov 201412:51 pmRNS3rd Quarter Results
5th Nov 20142:02 pmRNSHolding(s) in Company
28th Aug 20141:34 pmRNSHalf Yearly Report
30th Jun 20149:16 amRNSPosting of Annual Report
19th Jun 20149:02 amRNSAppointment of new CEO
17th Jun 20144:09 pmRNSResult of EGM / Directorate Change
2nd Jun 20146:15 pmRNSNotice of EGM
31st Mar 20147:00 amRNSFinal Results
17th Mar 20147:00 amRNSTrading Update
26th Feb 20147:00 amRNSHolding(s) in Company
4th Feb 20143:10 pmRNSHolding(s) in Company
17th Jan 20143:25 pmRNSChange of Adviser
7th Nov 20137:00 amRNSDisposal
29th Aug 20132:45 pmRNSHalf Yearly Report
19th Jun 20133:36 pmRNSDisposal
30th May 20139:33 amRNSPosting of Annual Report
9th May 20138:38 amRNSResult of AGM
22nd Apr 20134:08 pmRNSNotice of AGM
10th Apr 201310:50 amRNSNotice of AGM
22nd Mar 20134:03 pmRNSFinal Results
19th Mar 20133:11 pmRNSDisposal of Assets
10th Dec 20122:25 pmRNSReplacement - Loan Agreement
30th Nov 20123:04 pmRNSTrading Update
28th Nov 20124:48 pmRNSLoan Agreement
8th Nov 20129:10 amRNSFinancing Arrangements
22nd Aug 20122:06 pmRNSHalf Yearly Report
26th Jul 20129:45 amRNSNew Website
30th May 201211:12 amRNSDirectorate Change
28th Mar 20123:52 pmRNSTrade update
22nd Mar 20125:44 pmRNSResults for the year ended 31 December 2011
20th Mar 20124:05 pmRNSChange of Name
21st Feb 201211:51 amRNSNotice of AGM
23rd Jan 20124:04 pmRNSJoint Venture Companies
30th Nov 201112:43 pmRNSTrading Update
10th Nov 20114:14 pmRNSHolding(s) in Company
18th Aug 201111:04 amRNSHalf Yearly Report
13th Jul 20117:00 amRNSStatement re. Suspension
21st Apr 20113:36 pmRNSStatement re. Suspension
8th Apr 20117:00 amRNSAnnual Report 31.12.10
21st Mar 20111:42 pmRNSChange of Registered Office
7th Dec 20105:08 pmRNSHalf Yearly Report
27th Oct 20108:17 amRNSAnnual Financial Report
27th Oct 20108:17 amRNSAnnual Financial Report
22nd Oct 20108:56 amRNSFinal Results
22nd Oct 20108:56 amRNSFinal Results
7th Oct 20105:20 pmRNSSenior Managment Appointment
2nd Sep 20104:33 pmRNSDirectorate Change
12th Aug 201012:41 pmRNSRe Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.